Comment on: Increased Plasma ST2 Levels Precede the Development of Severe Acute GvHD and Chronic GvHD After Pediatric Hematopoietic Stem Cell Transplantation

Dettagli Bibliografici
Autori principali:	Yusa Pan, Jianjun Ding
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Increased Plasma ST2 Levels Precede the Development of Severe Acute GvHD and Chronic GvHD After Pediatric Hematopoietic Stem Cell Transplantation
di: Nakisa Kamari‐Kany, et al.
Pubblicazione: (2025)

Reply to: Comment on: Increased Plasma ST2 Levels Precede the Development of Severe Acute GvHD and Chronic GvHD After Pediatric Hematopoietic Stem Cell Transplantation
di: Nakisa Kamari‐Kany, et al.
Pubblicazione: (2025)

Increasing Access to Pediatric Allogeneic Hematopoietic Stem Cell Transplantation in South Africa
di: Candice Laverne Hendricks, et al.
Pubblicazione: (2026)

Syndecan‐1 is Associated With Sinusoidal Obstruction Syndrome and Severe Acute Graft‐Versus‐Host Disease After Pediatric Hematopoietic Stem Cell Transplantation
di: Denise Elbæk Horan, et al.
Pubblicazione: (2025)

Multiple Hematopoietic Stem Cell Transplantations in Pediatric Acute Myeloid Leukemia: Prognostic Significance of Remission and Severe Sinusoidal Obstruction Syndrome
di: Hideki Yoshida, et al.
Pubblicazione: (2025)

Soluble Thrombomodulin Is Associated With Endothelial Dysfunction Syndromes After Pediatric Hematopoietic Stem Cell Transplantation
di: Denise Elbæk Horan, et al.
Pubblicazione: (2025)

Comparing Comorbidity Indices to Predict Survival After Pediatric Hematopoietic Stem Cell Transplantation for Nonmalignant Disease
di: Roos Lotte Alexandra Bukman, et al.
Pubblicazione: (2025)

Procedural Sedation outside the Operating Room in Pediatric Hematopoietic Stem Cell Transplant Patients
di: Heather Xiao, et al.
Pubblicazione: (2026)

Living‐Donor Liver Transplantation for Chronic Hepatic Graft‐Versus‐Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation for XIAP Deficiency
di: Yuichi Mitani, et al.
Pubblicazione: (2025)

A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
di: Ava Momm, et al.
Pubblicazione: (2026)

Comparison of Letermovir Versus Ganciclovir for Cytomegalovirus Prophylaxis in Pediatric Hematopoietic Stem Cell Transplant Recipients
di: Catherine E. Martin, et al.
Pubblicazione: (2025)

Pediatric Mixed Phenotype Acute Leukemia With ETV6 :: ARNT Fusion Gene Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation
di: Yaoyao Rui, et al.
Pubblicazione: (2025)

Cognitive Functioning in Vorinostat‐Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant
di: Kristen L. Votruba, et al.
Pubblicazione: (2026)

Ultrasonographic Monitoring of Cytomegalovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation: A Case Report
di: Yuki Shimizu, et al.
Pubblicazione: (2026)

Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation in Children: A Single Pediatric Center Experience
di: Pauline Mazilier, et al.
Pubblicazione: (2025)

Bacterial and Parasitic Stool Studies Have Limited Utility in Pediatric Hematopoietic Stem Cell Transplant Patients
di: Matthew Nagy, et al.
Pubblicazione: (2025)

Bridging the Gap: Regional Disparities in Access to Pediatric Hematopoietic Stem Cell Transplantation (HSCT) in the Andean Subregion
di: Julia Palma, et al.
Pubblicazione: (2026)

Severe Precapillary Pulmonary Hypertension and Right Ventricular Failure After Hematopoietic Stem Cell Transplantation: Successful Outcomes With Aggressive Upfront Triple Therapy
di: Stine Andersen, et al.
Pubblicazione: (2025)

Reply to: Comment on: Ototoxicity in Pediatric Hematopoietic Stem Cell Transplantation With High Dose Carboplatin: Identifying Modifiable Risk Factors Through the Inclusion of Younger Patients
di: Anne Spence, et al.
Pubblicazione: (2025)

Controlling Renal Chronic Graft‐Versus‐Host Disease With a Belumosudil‐Containing Regimen After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
di: Yimin Wang, et al.
Pubblicazione: (2025)

Ototoxicity in Pediatric Hematopoietic Stem Cell Transplantation With High‐Dose Carboplatin: Identifying Modifiable Risk Factors Through the Inclusion of Younger Patients
di: Anne Spence, et al.
Pubblicazione: (2025)

Response to trametinib Monotherapy Without Hematopoietic Stem Cell Transplant in Juvenile Myelomonocytic Leukemia
di: Rozalyn Chok, et al.
Pubblicazione: (2026)

Analysis of Late Complications Associated With Hematopoietic Stem Cell Transplantation in Patients With Dyskeratosis Congenita
di: Takashi Koike, et al.
Pubblicazione: (2025)

Successful Outcome of Haploidentical Hematopoietic Stem Cell Transplantation in X‐Linked Sideroblastic Anemia
di: Vishnu Hari, et al.
Pubblicazione: (2026)

Imlifidase Utilization in Glanzmann Thrombasthenia With Anti‐GPIIb/IIIa and Anti‐HLA Alloimmunization and Severe Platelet Refractoriness Following Hematopoietic Stem Cell Transplant
di: Mohammad AlNajjar, et al.
Pubblicazione: (2024)

High Prevalence of Abnormal Baseline Lung Function in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Report from the TRANSPIRE Study
di: Jane Koo, et al.
Pubblicazione: (2025)

Major ABO Incompatibility in Non‐Myeloablative Hematopoietic Stem Cell Transplant for Sickle Cell Disease—Not an Insurmountable Obstacle
di: Kimberly Ji Eun Chung, et al.
Pubblicazione: (2025)

CD4 + Memory Stem‐Cell T Lymphocyte Frequency Is a Marker of Alloreactivity and a Predictor of Long‐Term Morbidity and Mortality After Hematopoietic Cell Transplantation
di: Petr Říha, et al.
Pubblicazione: (2025)

Diagnosing Acute Graft‐Versus‐Host Disease in Children Undergoing Hematopoietic Stem Cell Transplantation—Comparison of the Modified Glucksberg Criteria Versus the MAGIC Criteria
di: Sarah Weischendorff, et al.
Pubblicazione: (2025)

Post‐Transplant Cyclophosphamide for Graft‐Versus‐Host Disease Prophylaxis in Pediatric Stem Cell Transplantation
di: Aaron E. Fan, et al.
Pubblicazione: (2025)

Return‐to‐School Experiences of Adolescents After Allogeneic Hematopoietic Cell Transplant: A Qualitative Interview Study of Transplant Recipients
di: Olivia A. Do, et al.
Pubblicazione: (2024)

Bezlotoxumab as Treatment for Recurrent/Chronic Clostridioides difficile Infection in Pediatric Stem Cell Transplant Recipients: A Multi‐Institutional Experience
di: Aaron E. Fan, et al.
Pubblicazione: (2025)

Utility of Computed Tomography Surveillance of Asymptomatic Infection in Children and Young Adults Before Allogeneic Hematopoietic Stem Cell Transplant
di: Tyler Obermark, et al.
Pubblicazione: (2026)

Systematic Review of the Presentation, Treatment, and Outcome of Chronic Disseminated Candidiasis in Children With Cancer or Following Hematopoietic Cell Transplant
di: Emelia Eagling‐Every, et al.
Pubblicazione: (2025)

Continuous Kidney Replacement Therapy in Children With Sinusoidal Obstruction Syndrome After Hematopoietic Cell Transplant: Outcome and Liberation
di: Madeleine Heyn, et al.
Pubblicazione: (2024)

X‐Linked Sideroblastic Anemia Caused by ALAS2 Intron 1 Mutation Successfully Treated by Allogenic Hematopoietic Stem Cell Transplant
di: Shurui Du, et al.
Pubblicazione: (2026)

Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post‐Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation
di: Irtiza N. Sheikh, et al.
Pubblicazione: (2024)

Congenital Myelodysplastic Syndrome in a Newborn With Germline JAK2 Variant Treated With Liposomal Cytarabine–Daunorubicin and Allogeneic Hematopoietic Stem Cell Transplant
di: Kristin E. Zorn, et al.
Pubblicazione: (2025)

Parental Acceptance of Human Papillomavirus Vaccination Among Females Treated for Childhood Cancer and/or With Hematopoietic Stem Cell Transplantation: A Cross‐Sectional Study
di: Jiaoyang Cai, et al.
Pubblicazione: (2025)

Successful Management of Lineage Switch Infant Leukemia With Revumenib and Hematopoietic Cell Transplantation
di: Rachel E. Granberg, et al.
Pubblicazione: (2026)

Documenti analoghi

Documenti analoghi